Cel-Sci
CVM
#9791
Rank
A$70.03 M
Marketcap
A$8.33
Share price
-1.19%
Change (1 day)
-56.26%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : A$13.47 Million

According to Cel-Sci 's latest financial reports the company's total debt is A$13.47 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30A$14.19 M-15.53%
2024-09-30A$16.8 M-20.41%
2023-09-30A$21.11 M-11.26%
2022-09-30A$23.79 M7.72%
2021-09-30A$22.08 M13.57%
2020-09-30A$19.44 M-2.77%
2019-09-30A$20 M8%
2018-09-30A$18.52 M2.29%
2017-09-30A$18.1 M6.3%
2016-09-30A$17.03 M-14.01%
2015-09-30A$19.81 M1443.28%
2014-09-30A$1.28 M5.58%
2013-09-30A$1.21 M14.04%
2012-09-30A$1.06 M-79.22%
2011-09-30A$5.13 M348.24%
2010-09-30A$1.14 M-10.22%
2009-09-30A$1.27 M405.07%
2008-09-30A$0.25 M
2005-09-30A$0 M-5.61%
2004-09-30A$0 M-99.67%
2003-09-30A$1.28 M-60.57%
2002-09-30A$3.26 M5042.04%
2001-09-30A$0.06 M39.19%
2000-09-30A$0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$65.76 B 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$78.38 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$99.46 M 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$2.82 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$24.51 B 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$0.92 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.95 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$0.79 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA